SEC Company Response from CytoDyn Inc. (CYDY) (CIK 0001175680) (CYDY) — Feb 13, 2019
CytoDyn Inc. (CYDY) (CIK 0001175680)
Date: Feb. 13, 2019 · CIK: 0001175680 · Accession: 0001193125-19-037703
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-228991
Letter
CytoDyn Inc.
1111 Main Street, Suite 660
Vancouver, Washington 98660
February 13, 2019
VIA EDGAR SUBMISSION
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Re: REQUEST FOR ACCELERATION OF EFFECTIVENESS
CytoDyn Inc.
Registration Statement on Form S-3
File No. 333-228991
Ladies and Gentlemen:
CytoDyn Inc. (the “Company”) hereby respectfully requests the acceleration of the effectiveness of the above-referenced Registration Statement (the “Registration Statement”) so that the Registration Statement will become effective at 9:00 a.m. (Eastern time) on Thursday, February 14, 2019, or as soon thereafter as practicable.
Please notify James O’Grady of Lowenstein Sandler LLP, counsel to the Company, at (646) 414-6849 or jogrady@lowenstein.com, as soon as the Registration Statement has been declared effective.
Very truly yours,
CytoDyn Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver, Washington 98660 February 13, 2019 VIA EDGAR SUBMISSION United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Re: REQUEST FOR ACCELERATION OF EFFECTIVENESS CytoDyn Inc. Registration Statement on Form S-3 File No. 333-228991 Ladies and Gentlemen: CytoDyn Inc. (the “Company”) hereby respectfully requests the acceleration of the effectiveness of the above-referenced Registration Statement (the “Registration Statement”) so that the Registration Statement will become effective at 9:00 a.m. (Eastern time) on Thursday, February 14, 2019, or as soon thereafter as practicable. Please notify James O’Grady of Lowenstein Sandler LLP, counsel to the Company, at (646) 414-6849 or jogrady@lowenstein.com, as soon as the Registration Statement has been declared effective. Very truly yours, CytoDyn Inc. /s/ Michael D. Mulholland Michael D. Mulholland Chief Financial Officer